Pages that link to "Q43986196"

The following pages link to Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study (Q43986196):

Displaying 24 items.

• Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. (Q31046235) (← links)
• Assessing risk to benefit ratio in antiepileptic drug therapy (Q34001648) (← links)
• Fetal heart rate decelerations during ECT-induced seizures: is it important? (Q34166065) (← links)
• Treatment issues for women with epilepsy (Q34254779) (← links)
• Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. (Q34544208) (← links)
• Management of epilepsy during pregnancy (Q34722379) (← links)
• Managing epilepsy in women of childbearing age. (Q34977403) (← links)
• Anti-epileptic drugs in pregnancy: current safety and other issues (Q35095179) (← links)
• Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation (Q35147180) (← links)
• Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful? (Q36603158) (← links)
• Obstetric risks for women with epilepsy during pregnancy (Q36998332) (← links)
• Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts (Q37138858) (← links)
• Teratogenicity and antiepileptic drugs: potential mechanisms (Q37301544) (← links)
• Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis (Q38576026) (← links)
• Maternal nutrition and obstetric outcome (Q41143702) (← links)
• The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome (Q41240632) (← links)
• Maximizing the Health of Women with Epilepsy: Science and Ethics in New Drug Development (Q41548040) (← links)
• Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy (Q43472317) (← links)
• Pregnancy registries in epilepsy (Q43906040) (← links)
• Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate (Q44237611) (← links)
• Maternal periconceptional biochemical and hematological parameters, vitamin profiles and pregnancy outcome (Q44568024) (← links)
• Epilepsy and pregnancy: lamotrigine as main drug used (Q44678739) (← links)
• Pregnancy and epilepsy (Q74714397) (← links)
• The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero: a retrospective population-based study (Q79830201) (← links)